Clearmind Announces Positive Safety Findings For Cmnd 100, Demonstrating Consistent Tolerability Throughout Full Dose Escalation In Part A Of Its FDA-Regulated Clinical Trial
CMND•Clearmind reports positive safety findings for CMND-100
July 30 (Reuters) - Clearmind Medicine Inc CMND.O:
- Clearmind announces positive safety findings for CMND 100, demonstrating consistent tolerability throughout full dose escalation in Part A of its FDA-regulated clinical trial
- Clearmind Medicine - all 24 participants successfully complete treatment in Part A of CMND-100 trial
- Clearmind Medicine - no serious adverse events observed in Part A of CMND-100 trial
- Clearmind Medicine - study achieves primary endpoint of safety and tolerability for CMND-100
